LncRNA-42060 Regulates Tamoxifen Sensitivity and Tumor Development via Regulating the miR-204-5p/SOX4 Axis in Canine Mammary Gland Tumor Cells

Tamoxifen is the drug of choice for endocrine therapy of breast cancer. Its clinical use is limited by the development of drug resistance. There is increasing evidence that long non-coding RNAs (lncRNAs) are associated with tumor drug resistance. Therefore, we established two TAM-resistant cell line...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Enshuang, Hu, Mengxin, Ge, Reidong, Tong, Danning, Fan, Yuying, Ren, Xiaoli, Liu, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255626/
https://www.ncbi.nlm.nih.gov/pubmed/34235197
http://dx.doi.org/10.3389/fvets.2021.654694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255626/
https://www.ncbi.nlm.nih.gov/pubmed/34235197
http://dx.doi.org/10.3389/fvets.2021.654694

Ejemplares similares